MedPath

Preventing Childhood Antibiotic-associated Diarrhea by Prebiotics

Phase 3
Completed
Conditions
Antibiotic-Associated Diarrhea
Registration Number
NCT00826137
Lead Sponsor
Soroka University Medical Center
Brief Summary

Prospective randomized double-blind study on the effect of prebiotics (inulin and fructo-oligosaccharides) in the prevention of antibiotic-associated diarrhea in children.

Detailed Description

Group will get either the product or placebo blindly throughout antibiotic treatment with additional 14 days.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Healthy children with acute infection.
Exclusion Criteria
  • Hypersensitivity to antibiotics, chronic illness.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Prevention of diarrhea.During antibiotic treatment+14 days
Secondary Outcome Measures
NameTimeMethod
Duration of diarrhea.During antibiotic treatment+14 days

Trial Locations

Locations (1)

Soroka Medical Center

🇮🇱

Beer-Sheva, Israel

Soroka Medical Center
🇮🇱Beer-Sheva, Israel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.